{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:37:17Z","timestamp":1791005837266,"version":"4.1.0"},"reference-count":55,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Advanced liver fibrosis is increasing globally, with women experiencing faster progression despite lower prevalence. Cardiometabolic risk factors (CMRFs) may be differentially associated with fibrosis risk by sex.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To examine sex differences in the association between individual CMRFs and significant liver fibrosis among US adults.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This population-based, cross-sectional study was conducted using data from the US National Health and Nutrition Examination Survey, 2017 to 2020. Adults aged 20 years or older with valid transient elastography measurements were included. Data were analyzed from July 2024 through December 2025.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n CMRFs, including high waist circumference (&amp;gt;102 cm in men or 88 cm in women), glucose intolerance, hypertension, hypertriglyceridemia, and low high-density lipoprotein cholesterol levels, were assessed, as well as obesity (body mass index \u226530 or \u226527.5 for Asian participants) and the presence of 2 or more CMRFs.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Clinically significant fibrosis was defined as a liver stiffness of 8.0 kPa or greater by transient elastography. Multivariable logistic regression evaluated associations between CMRFs and significant fibrosis, adjusting for age, sex, race and ethnicity, smoking, and alcohol and testing CMRF by sex interactions.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The study population of 5981 participants included 2992 women (weighted percentage: 50.2% [95% CI, 48.2%-52.2%]; 14.7% Hispanic [95% CI, 12.0%-18.0%], 11.0% non-Hispanic Black [95% CI, 8.2%-14.7%], and 65.0% non-Hispanic White [95% CI, 59.4%-70.3%]; mean age, 49 years [95% CI, 48-50 years]) and 2989 men (weighted percentage: 49.8% [95% CI, 47.8%-51.8%]; 16.4% Hispanic [95% CI, 13.2%-20.2%], 9.4% non-Hispanic Black [95% CI, 7.3%-11.9%], and 64.6% non-Hispanic White [95% CI, 59.6%-69.3%]; mean age, 47 years [95% CI, 46-48 years]). Women had higher prevalence of high waist circumference (69.0% [95% CI, 66.1%-71.7%] vs 48.6% [95% CI, 44.3%-53.1%]) and lower prevalence of hypertension (41.0% [95% CI, 38.2%-43.8%] vs 44.9% [95% CI, 41.5%-48.4%]), glucose intolerance (31.1% [95% CI, 28.7%-33.5%] vs 41.7% [95% CI, 38.6%-44.9%]), and hypertriglyceridemia (36.6% [95% CI, 34.0%-39.3%] vs 48.8% [95% CI, 44.6%-52.9%]) compared with men. The prevalence of significant fibrosis was 6.9% (95% CI, 5.4%-8.8%) in women and 10.7% (95% CI, 8.8%-12.9%) in men. The point estimates in the association with significant fibrosis were significantly greater in women vs men for high waist circumference (adjusted odds ratio [aOR], 13.45 [95% CI, 5.70-31.78] vs aOR, 4.44 [95% CI, 3.00-6.57];\n P<\/jats:italic>\n for interaction\u2009=\u2009.01), glucose intolerance (aOR, 2.94 [95% CI, 1.64-5.28] vs aOR, 1.51 [95% CI, 1.08-2.13];\n P<\/jats:italic>\n for interaction\u2009=\u2009.045), and the presence of 2 or more CMRFs (aOR, 10.22 [95% CI, 4.76-21.95] vs aOR, 2.87 [95% CI, 1.91-4.31];\n P<\/jats:italic>\n for interaction\u2009=\u2009.002).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this study, the presence of 2 or more CMRFs was associated with a greater increase in risk of significant fibrosis for women compared with men. Central adiposity and glucose intolerance were also associated with greater increases in risk among women.. These findings support the need for sex-specific screening approaches.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.0863","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T15:00:27Z","timestamp":1773068427000},"page":"e260863","source":"Crossref","is-referenced-by-count":4,"title":["Sex-Specific Cardiometabolic Profiles and Severity of Liver Fibrosis"],"prefix":"10.1001","volume":"9","author":[{"given":"Somaya","family":"Albhaisi","sequence":"first","affiliation":[{"name":"Division of Gastrointestinal and Liver Diseases, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah","family":"Terrault","sequence":"additional","affiliation":[{"name":"Division of Gastrointestinal and Liver Diseases, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Dodge","sequence":"additional","affiliation":[{"name":"Division of Gastrointestinal and Liver Diseases, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles"},{"name":"Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"issue":"1","key":"zoi260058r1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cgh.2020.04.067","article-title":"Women have a lower risk of nonalcoholic fatty liver disease but a higher risk of progression vs men: a systematic review and meta-analysis.","volume":"19","author":"Balakrishnan","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"zoi260058r2","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps.","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"zoi260058r3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"zoi260058r4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/hep.31608","article-title":"Hepatic fibrosis associates with multiple cardiometabolic disease risk factors: the Framingham Heart Study.","volume":"73","author":"Long","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"zoi260058r5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12902-022-01046-y","article-title":"Association between type 2 diabetes status and prevalence of liver steatosis and fibrosis among adults aged?=?40 years.","volume":"22","author":"Chen","year":"2022","journal-title":"BMC Endocr Disord"},{"issue":"8","key":"zoi260058r6","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1097\/MEG.0000000000002977","article-title":"Heterogeneity of cardiometabolic and hepatic fibrosis risks in nonalcoholic fatty liver disease among lean, overweight, and obese populations: a multicenter cross-sectional study.","volume":"37","author":"Gao","year":"2025","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"zoi260058r7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101388","article-title":"Impact of cardiometabolic risk factors on hepatic fibrosis and clinical outcomes in MASLD: a population-based multi-cohort study.","volume":"7","author":"Park","year":"2025","journal-title":"JHEP Rep"},{"issue":"11","key":"zoi260058r8","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1136\/gutjnl-2023-330110","article-title":"Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis.","volume":"72","author":"En Li Cho","year":"2023","journal-title":"Gut"},{"key":"zoi260058r9","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155642","article-title":"Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States.","volume":"146","author":"Golabi","year":"2023","journal-title":"Metabolism"},{"key":"zoi260058r10","doi-asserted-by":"publisher","DOI":"10.1016\/j.hnm.2023.200210","article-title":"Visceral fat: A key mediator of NAFLD development and progression.","volume":"33","author":"Bansal","year":"2023","journal-title":"Hum Nutr Metab"},{"issue":"4","key":"zoi260058r11","doi-asserted-by":"publisher","first-page":"10006","DOI":"10.70322\/fibrosis.2024.10006","article-title":"Sex and gender differences in liver fibrosis: pathomechanisms and clinical outcomes.","volume":"2","author":"Jamalinia","year":"2024","journal-title":"Fibrosis (Hong Kong)"},{"issue":"19","key":"zoi260058r15","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","journal-title":"JAMA"},{"issue":"9","key":"zoi260058r16","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.39575","article-title":"Body roundness index and waist-to-height ratio are strongly associated with non-alcoholic fatty liver disease: a population-based study.","volume":"16","author":"Motamed","year":"2016","journal-title":"Hepat Mon"},{"issue":"5","key":"zoi260058r17","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease.","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"zoi260058r18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement.","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"8","key":"zoi260058r19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220612","article-title":"Increasing metabolic co-morbidities are associated with higher risk of advanced fibrosis in nonalcoholic steatohepatitis.","volume":"14","author":"Wong","year":"2019","journal-title":"PLoS One"},{"issue":"11","key":"zoi260058r20","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1007\/s00125-024-06196-3","article-title":"EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): executive summary.","volume":"67","author":"European Association for the Study of the Liver","year":"2024","journal-title":"Diabetologia"},{"issue":"1","key":"zoi260058r21","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/jgh.16787","article-title":"Cardiometabolic risk factors and coronary atherosclerosis progression in patients with metabolic dysfunction-associated steatotic liver disease: the influential role of quantity over type.","volume":"40","author":"Kim","year":"2025","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"zoi260058r22","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000019","article-title":"Prevalence of at-risk NASH and its association with metabolic syndrome in US adults with NAFLD, 2017-2018.","volume":"7","author":"Payne","year":"2023","journal-title":"Hepatol Commun"},{"issue":"6","key":"zoi260058r23","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature.","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"13","key":"zoi260058r24","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.3390\/nu17132229","article-title":"Alcohol consumption and liver metabolism in the era of MASLD: integrating nutritional and pathophysiological insights.","volume":"17","author":"Acierno","year":"2025","journal-title":"Nutrients"},{"issue":"6","key":"zoi260058r25","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1002\/hep.29055","article-title":"Is moderate alcohol use in nonalcoholic fatty liver disease good or bad: a critical review.","volume":"65","author":"Ajmera","year":"2017","journal-title":"Hepatology"},{"issue":"3","key":"zoi260058r26","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/HEP.0000000000000604","article-title":"National prevalence estimates for steatotic liver disease and subclassifications using consensus nomenclature.","volume":"79","author":"Lee","year":"2024","journal-title":"Hepatology"},{"issue":"5","key":"zoi260058r27","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis.","volume":"66","author":"Karlas","year":"2017","journal-title":"J Hepatol"},{"issue":"9","key":"zoi260058r28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200656","article-title":"Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based study.","volume":"13","author":"Fabrellas","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"zoi260058r29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis.","volume":"63","author":"European Association for Study of Liver","year":"2015","journal-title":"J Hepatol"},{"issue":"2","key":"zoi260058r30","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease.","volume":"51","author":"Wong","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"zoi260058r31","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update.","volume":"75","author":"Berzigotti","year":"2021","journal-title":"J Hepatol"},{"issue":"12","key":"zoi260058r32","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1016\/j.cgh.2025.01.003","article-title":"Association of alcohol and incremental cardiometabolic risk factors with liver disease: a national cross-sectional study.","volume":"23","author":"Lee","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"zoi260058r33","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.jhep.2025.06.020","article-title":"Prevalence, severity and determinants of steatotic liver disease among individuals with metabolic and alcohol risk from the community.","volume":"83","author":"Hansen","year":"2025","journal-title":"J Hepatol"},{"issue":"11","key":"zoi260058r34","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1002\/oby.20408","article-title":"Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model.","volume":"21","author":"Thomas","year":"2013","journal-title":"Obesity (Silver Spring)"},{"issue":"12","key":"zoi260058r35","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.molmed.2024.05.013","article-title":"Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease.","volume":"30","author":"Cherubini","year":"2024","journal-title":"Trends Mol Med"},{"issue":"4","key":"zoi260058r36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.20517\/mtod.2025.131","article-title":"Sex and gender differences in MASLD: pathophysiological mechanisms, clinical implications, and future directions.","volume":"5","author":"Jamalinia","year":"2025","journal-title":"Metab Target Organ Damage"},{"issue":"9","key":"zoi260058r37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11892-018-1031-3","article-title":"Gender and sex differences in adipose tissue.","volume":"18","author":"Chang","year":"2018","journal-title":"Curr Diab Rep"},{"issue":"11","key":"zoi260058r38","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.019968","article-title":"Sex differences in the associations of visceral adipose tissue and cardiometabolic and cardiovascular disease risk: the Framingham Heart Study.","volume":"10","author":"Kammerlander","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"zoi260058r39","doi-asserted-by":"publisher","DOI":"10.1155\/jobe\/7240063","article-title":"Sex-specific differences in visceral and subcutaneous adiposity accumulation and their association with metabolic abnormalities.","volume":"2025","author":"Rodrigues","year":"2025","journal-title":"J Obes"},{"issue":"9","key":"zoi260058r40","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014740","article-title":"Relationship between inflammatory markers and visceral obesity in obese and overweight Korean adults: an observational study.","volume":"98","author":"Yu","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"zoi260058r41","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1576599","article-title":"Visceral adiposity loss is associated with improvement in cardiometabolic markers: findings from a dietary intervention study.","volume":"16","author":"Abdullah","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"zoi260058r42","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1034\/j.1600-0676.2003.00811.x","article-title":"Impact of oestrogens on the progression of liver disease.","volume":"23","author":"Shimizu","year":"2003","journal-title":"Liver Int"},{"issue":"6","key":"zoi260058r43","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1002\/hep.20463","article-title":"Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure.","volume":"40","author":"Di Martino","year":"2004","journal-title":"Hepatology"},{"issue":"3","key":"zoi260058r44","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00125-019-05040-3","article-title":"Sex differences in metabolic regulation and diabetes susceptibility.","volume":"63","author":"Tramunt","year":"2020","journal-title":"Diabetologia"},{"key":"zoi260058r45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.molmet.2018.05.008","article-title":"Sex differences in lipid and lipoprotein metabolism.","volume":"15","author":"Palmisano","year":"2018","journal-title":"Mol Metab"},{"key":"zoi260058r46","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13293-015-0033-y","article-title":"Sex differences in metabolic homeostasis, diabetes, and obesity.","volume":"6","author":"Mauvais-Jarvis","year":"2015","journal-title":"Biol Sex Differ"},{"key":"zoi260058r47","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1604398","article-title":"Association between body roundness index and risks of all-cause and cardiovascular mortality in adults with metabolic dysfunction-associated steatotic liver disease: NHANES 1999-2018.","volume":"12","author":"Yi","year":"2025","journal-title":"Front Nutr"},{"issue":"6","key":"zoi260058r48","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.15051","article-title":"Body roundness index and all-cause mortality among US adults.","volume":"7","author":"Zhang","year":"2024","journal-title":"JAMA Netw Open"},{"key":"zoi260058r49","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1178829","article-title":"The mediatory effect of inflammatory markers on the association between a body shape index and body roundness index with cardiometabolic risk factor in overweight and obese women: a cross-sectional study.","volume":"10","author":"Mirzababaei","year":"2023","journal-title":"Front Nutr"},{"issue":"1","key":"zoi260058r50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/2042-6410-3-13","article-title":"Sex differences in human adipose tissues\u2014the biology of pear shape.","volume":"3","author":"Karastergiou","year":"2012","journal-title":"Biol Sex Differ"},{"issue":"3","key":"zoi260058r51","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/ajcn\/74.3.315","article-title":"Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family Study.","volume":"74","author":"Seidell","year":"2001","journal-title":"Am J Clin Nutr"},{"issue":"Suppl 1","key":"zoi260058r52","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.genm.2009.02.002","article-title":"Gender differences in insulin resistance, body composition, and energy balance.","volume":"6","author":"Geer","year":"2009","journal-title":"Gend Med"},{"issue":"19","key":"zoi260058r53","doi-asserted-by":"publisher","first-page":"6216","DOI":"10.3390\/jcm12196216","article-title":"Metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: the patient and physician perspective.","volume":"12","author":"Eskridge","year":"2023","journal-title":"J Clin Med"},{"issue":"7","key":"zoi260058r54","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S2468-1253(23)00066-3","article-title":"Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.","volume":"8","author":"Tincopa","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"zoi260058r55","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease.","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"key":"zoi260058r12","unstructured":"Akinbami? LJ, Chen? TC, Davy? O, . National Health and Nutrition Examination Survey, 2017\u2013March 2020 prepandemic file: sample design, estimation, and analytic guidelines. Accessed May 17, 2025. https:\/\/stacks.cdc.gov\/view\/cdc\/115434"},{"key":"zoi260058r13","unstructured":"National Center for Health Statistics. Health, United States: National Health and Nutrition Examination Survey (NHANES). July 29, 2024. Accessed September 16, 2025. https:\/\/www.cdc.gov\/nchs\/hus\/sources-definitions\/nhanes.htm"},{"key":"zoi260058r14","unstructured":"National Health and Nutrition Examination Survey. Liver ultrasound transient elastography (LUX_L). Accessed January 10, 2026. https:\/\/wwwn.cdc.gov\/Nchs\/Data\/Nhanes\/Public\/2021\/DataFiles\/LUX_L.htm"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2846021\/albhaisi_2026_oi_260058_1772485149.82589.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T15:00:28Z","timestamp":1773068428000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2846021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.0863","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]}}}